The company received the Innovation Passport in the UK for zilebesiran, an investigational treatment of hypertension

Updated Date: Tue, 31 May 2022 00:00:00 EDT

Updated Date: Tue, 31 May 2022 00:00:00 EDT

Updated Date: Tue, 31 May 2022 00:00:00 EDT

Updated Date: Tue, 31 May 2022 00:00:00 EDT

Updated Date: Tue, 31 May 2022 00:00:00 EDT

Doctors’ groups in the US are renewing their push for gun control after a traumatic fortnight of shootings […]

The UK government is to amend the law to enable it to list monkeypox as a notifiable disease […]

Perhaps medicine is best understood when it confronts death. “That distinguished thing,” as Henry James called it, highlights […]

New insights into how some bacteria survive antibiotics could lead to the development of novel treatment strategies.